Table 3.
Preoperative and Postoperative Lysholm Knee Scoring Scale and International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form Scores
| Treatment Group | ||||||
|---|---|---|---|---|---|---|
| AMUC Group | PRP Group | Control Group | ||||
| Time Point | Lysholm | IKDC | Lysholm | IKDC | Lysholm | IKDC |
| Baseline | 44.26 ± 21.98 | 36.43 ± 17.06 | 48.41 ± 14.38 | 40.26 ± 2.73 | 48.35 ± 22.73 | 41.07 ± 19.99 |
| 3 months | 66.47 ± 21.79 | 59.61 ± 16.91 | 65.58 ± 24.63 | 56.38 ± 20.76 | 59.70 ± 22.02 | 48.18 ± 21.07 |
| 0.0046 | 0.0003 | 0.0117 | 0.0053 | 0.0189 | 0.1127 | |
| 6 months | 67.43 ± 24.45 | 60.09 ± 22.44 | 56.64 ± 25.50 | 47.85 ± 20.79 | 60.24 ± 25.90 | 52.17 ± 26.23 |
| 0.0508 | 0.0322 | 0.3355 | 0.2772 | 0.0482 | 0.0610 | |
| 12 months | Low n | Low n | 56.00 ± 22.52 | 44.06 ± 16.11 | 57.36 ± 29.92 | 50.53 ± 28.53 |
| 0.6216 | 0.7263 | 0.3669 | 0.3184 | |||
Notes: Data are presented as mean ± SD. The term Low n indicates inadequate sample size. For the Lysholm Knee Scoring Scale and the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, higher scores indicate better outcomes. P values reflect the statistical significance of the change from baseline.
AMUC, amniotic umbilical cord tissue; PRP, platelet-rich plasma.